[1]
“Stability indicating RP-LC-PDA method for the quantitative analysis of saxagliptin in pharmaceutical dosage form”, Braz. J. Pharm. Sci., vol. 51, no. 2, pp. 461–466, Jun. 2015, doi: 10.1590/S1984-82502015000200023.